Celldex Therapeutics Inc (CLDX)
Working Capital Ratio
84.82%
Quarterly · Period ending:

CLDX Working Capital Ratio
Latest reported84.82%period ending
Latest reported84.82%period ending
CLDX Quarterly Working Capital Ratio (71.88% → 84.82%)
Quarterly working capital ratio
High-resolution chart · PNG
CLDX working capital ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Working Capital Ratio |
|---|---|
| 69.8041% | |
| 73.706% | |
| 73.012% | |
| 86.2972% | |
| 69.557% | |
| 70.8027% | |
| 61.8085% | |
| 66.6667% | |
| 46.6667% | |
| 49.2386% | |
| 54.185% | |
| 53.7849% | |
| 48.9796% | |
| 59.4828% | |
| 46.9388% | |
| 58.2609% | |
| 71.6418% | |
| 74.6667% | |
| 68.0233% | |
| 72.5389% | |
| 51.2821% | |
| 51.5528% | |
| 60.5405% | |
| 50.4274% | |
| 66.443% | |
| 70.5556% | |
| 72.9469% | |
| 68.3794% | |
| 72.3022% | |
| 76.5472% | |
| 78.852% | |
| 62.2093% | |
| 68.75% | |
| 71.4286% | |
| 74.5902% | |
| 75.6757% | |
| 77.037% | |
| 80.3571% | |
| 80.9859% | |
| 81.5436% | |
| 59.0909% | |
| 62.2047% | |
| 64.4444% | |
| 61.1842% | |
| 65.3846% | |
| 61.8644% | |
| 62.1212% | |
| 79.2308% | |
| 84.2466% | |
| 71.875% |